T. Fujihara et al.
Bull. Chem. Soc. Jpn. Vol. 82, No. 9 (2009) 1191
1H NMR (CDCl3): ¤ 0.98 (s, 18H), 1.14 (s, 9H), 1.28 (s, 9H),
5,11,17,23,29,35-Hexa-tert-butyl-37-(3-diphenylphosphino-
1.30 (s, 18H), 2.34 (s, 6H, OCH3), 2.71 (s, 3H, OCH3), 3.03 (d,
benzyloxy-38,39,40,41,42-pentamethoxycalix[6]arene
(1b).
2
2H, ArCH2Ar, JH,H = 15 Hz), 3.34 (s, 6H, OCH3), 3.65 (d, 2H,
The compound was synthesized with 6b (0.65 g, 0.49 mmol) and
PhSiH3 (1.8 mL, 15 mmol) by a method similar to that used for
1a. White solids were obtained (0.59 g, 90%). HR-ESI-MS m/z
calcd for [C90H109O6P + Na]+: 1339.7860; found: 1339.7844.
1H NMR (CDCl3): ¤ 0.93 (s, 9H), 1.01 (s, 18H), 1.25 (s, 9H),
1.27 (s, 18H), 2.46 (s, 6H, OCH3), 2.75 (s, 3H, OCH3), 3.27 (s,
2
2
ArCH2Ar, JH,H = 15 Hz), 3.80 (d, 2H, ArCH2Ar, JH,H = 15 Hz),
2
3.95 (br.s, 2H, ArCH2Ar), 4.08 (d, 2H, ArCH2Ar, JH,H = 15 Hz),
4.20 (d, 2H, ArCH2Ar, JH,H = 15 Hz), 5.10 (s, 2H), 6.71 (s, 2H),
2
6.78 (s, 2H), 6.85 (s, 2H), 7.00 (s, 3H), 7.10 (br.s, 3H), 7.16 (s,
1H), 7.45 (br.s, 6H), 7.62 (br.s, 6H), 8.27 (br.s, 1H); 13C{1H} NMR
(CDCl3): ¤ 29.92, 30.56, 30.65, 31.26, 31.37, 31.50, 31.65, 34.14,
34.21, 34.26, 59.96, 60.04, 60.18, 71.30, 124.09, 124.89, 126.05,
2
6H, OCH3), 3.42 (d, 2H, ArCH2Ar, JH,H = 15 Hz), 3.67 (d, 2H,
2
2
ArCH2Ar, JH,H = 15 Hz), 3.80 (d, 2H, ArCH2Ar, JH,H = 15 Hz),
4.08 (d, 2H, ArCH2Ar, 2JH,H = 15 Hz), 4.20 (d, 2H, ArCH2Ar,
2JH,H = 15 Hz), 4.38 (d, 2H, ArCH2Ar, 2JH,H = 15 Hz), 4.84 (s,
2H), 6.82 (s, 2H), 6.83 (s, 2H), 6.89 (s, 2H), 7.11 (s, 2H), 7.13 (s,
2H), 7.20 (s, 2H), 7.25-7.34 (m, 11H), 7.37 (t, 1H, J = 10 Hz),
7.42 (d, 1H, J = 8 Hz), 7.58 (d, 1H, J = 8 Hz); 13C{1H} NMR
(CDCl3): ¤ 30.45, 30.64, 30.70, 31.31, 31.40, 31.59, 31.63, 34.15,
34.25, 59.94, 60.00, 60.13, 74.44, 124.48, 124.95, 125.14, 126.92,
3
126.56, 126.92, 127.15, 127.81, 128.73 (d, JP,C = 11 Hz), 132.02
(d, 3JP,C = 12 Hz), 132.17, 132.71, 132.84, 132.99, 133.24, 133.27,
133.60 (d, 2JP,C = 13 Hz), 133.79 (d, 2JP,C = 12 Hz), 143.80,
143.86, 145.64, 145.72, 145.76, 146.00, 151.37, 153.52, 153.95,
154.40; 31P{1H} NMR (CDCl3): ¤ 32.9.
5,11,17,23,29,35-Hexa-tert-butyl-37-(2-diphenylphosphino-
benzyloxy)-38,39,40,41,42-pentamethoxycalix[6]arene (1a).
A
2
solution of 6a (1.70 g, 1.3 mmol) in toluene (25 mL) was refluxed
in the presence of PhSiH3 (4.7 mL, 38 mmol) for 2 d. The solvent
was then removed under reduced pressure and the residue
dissolved in CH2Cl2 (ca. 2 mL). Reprecipitation with MeOH
afforded the product as white solids. An analytically pure
product was obtained by recrystallization from CH2Cl2/MeOH
(2:5). White solids were obtained (1.04 g, 62%). Anal. Calcd for
C90H109O6P¢CH3OH: C, 80.97; H, 8.44%. Found: C, 80.99; H,
8.48%. HR-ESI-MS m/z calcd for [M + Na]+: 1339.7860; found:
127.01, 127.48, 128.58 (d, JP,C = 7 Hz), 128.78, 133.20, 133.26,
2
133.31, 133.43, 133.69 (d, JP,C = 8 Hz), 133.93, 137.10, 137.22,
138.10, 138.18, 145.72, 145.74, 145.96; 31P{1H} NMR (CDCl3):
¤ ¹4.79.
37-(2-Diphenylphosphinoylbenzyloxy)-38,39,40,41,42-penta-
methoxycalix[6]arene (7a). The compound was synthesized with
5a (1.18 g, 3.2 mmol) and 4 (1.87 g, 2.7 mmol) by a method similar
to that used for 6a. Pale-yellow solids were obtained (1.37 g, 52%).
HR-ESI-MS m/z calcd for [C66H61O7P + Na]+: 1020.1499; found:
1
1
1339.7833. H NMR (CDCl3): ¤ 1.00 (s, 18H), 1.13 (s, 9H), 1.26
1019.4050. H NMR (CDCl3): ¤ 2.75 (s, 6H, OCH3), 3.24 (s, 9H,
(s, 9H), 1.27 (s, 18H), 2.40 (s, 6H, OCH3), 2.73 (s, 3H, OCH3),
OCH3), 3.59 (s, 4H, ArCH2Ar), 3.89 (s, 4H, ArCH2Ar), 3.96 (s,
4H, ArCH2Ar), 5.22 (s, 2H), 6.68-6.73 (m, 3H), 6.80-6.83 (m,
4H), 6.89 (t, 2H, J = 8 Hz), 6.94-7.02 (m, 10H), 7.44 (br.t, 4H,
J = 8 Hz), 7.51 (t, 2H, J = 7 Hz), 7.57-7.64 (m, 6H), 8.11 (m, 1H);
13C{1H} NMR (CDCl3): ¤ 29.86, 30.30, 30.39, 60.08, 60.15,
60.48, 71.86, 123.30, 123.48, 123.54, 123.90, 127.72, 128.61,
128.75 (d, 3JP,C = 11 Hz), 128.88, 129.26, 129.52, 130.26, 132.09,
132.14, 132.18, 132.67, 134.39, 134.45, 134.59, 134.74, 153.83,
156.17, 156.43, 156.70; 31P{1H} NMR (CDCl3): ¤ 32.9.
2
3.27 (s, 6H, OCH3), 3.35 (d, 2H, ArCH2Ar, JH,H = 15 Hz), 3.67
2
2
(d, 2H, ArCH2Ar, JH,H = 15 Hz), 3.83 (d, 2H, ArCH2Ar, JH,H
=
15 Hz), 4.03 (d, 2H, ArCH2Ar, 2JH,H = 15 Hz), 4.16 (d, 2H,
2
2
ArCH2Ar, JH,H = 15 Hz), 4.32 (d, 2H, ArCH2Ar, JH,H = 15 Hz),
5.14 (s, 2H), 6.79 (s, 2H), 6.81 (s, 2H), 6.88 (s, 2H), 7.00 (s, 2H),
7.09-7.31 (m, 13H), 7.41 (t, 2H, J = 8 Hz), 7.62 (t, 1H, J = 8 Hz),
8.00 (m, 2H); 13C{1H} NMR (CDCl3): ¤ 30.50, 31.29, 31.39,
31.48, 31.62, 34.14, 34.20, 34.25, 59.90, 59.94, 126.87, 128.59 (d,
2JP,C = 8 Hz), 128.79, 133.20, 133.26, 133.43, 133.56, 133.71,
133.82, 133.92, 134.01, 136.03, 145.58, 154.50; 31P{1H} NMR
(CDCl3): ¤ ¹15.6.
37-(2-Diphenylphosphinobenzyloxy)-38,39,40,41,42-penta-
methoxycalix[6]arene (2a). The compound was synthesized with
7a (1.37 g, 1.4 mmol) and PhSiH3 (5.0 mL, 41 mmol) by a method
similar to that used for 1a. White solids were obtained (0.89 g,
66%). HR-ESI-MS m/z calcd for [C66H61O6P + Na]+: 1003.4103;
5,11,17,23,29,35-Hexa-tert-butyl-37-(3-diphenylphosphinoyl-
benzyloxy)-38,39,40,41,42-pentamethoxycalix[6]arene
(6b).
1
The compound was synthesized with 3 (1.0 g, 1.0 mmol) and 3-
diphenylphosphinoylbenzyl bromide (5b, 0.35 g, 1.4 mmol) by a
method similar to that used for 6a. Pale-yellow solids were
obtained (1.1 g, 88%). Anal. Calcd for C90H109O7P¢CHCl3: C,
75.21; H, 7.63%. Found: C, 75.00; H, 7.85%. HR-ESI-MS m/z
calcd for [M + Na]+: 1355.7809; found: 1355.7806. 1H NMR
(CDCl3): ¤ 0.92 (s, 9H), 0.98 (s, 18H), 1.25 (s, 9H), 1.26 (s, 18H),
2.42 (s, 6H, OCH3), 2.71 (s, 3H, OCH3), 3.30 (s, 6H, OCH3), 3.39
found: 1003.4113. H NMR (CDCl3): ¤ 2.82 (s, 6H, OCH3), 3.20
(s, 6H, OCH3), 3.24 (s, 3H, OCH3), 3.85 (s, 4H, ArCH2Ar), 3.91
(s, 4H, ArCH2Ar), 3.97 (s, 4H, ArCH2Ar), 5.13 (s, 2H), 6.72
(t, 1H, J = 8 Hz), 6.78-7.31 (m, 29H), 7.39 (t, 1H, J = 7 Hz), 7.84
(m, 1H); 13C{1H} NMR (CDCl3): ¤ 30.30, 30.38, 60.11, 60.45,
72.40, 123.35, 123.51, 123.82, 127.21, 127.67, 127.84, 128.69 (d,
2JP,C = 6 Hz), 128.91, 128.98, 129.16, 129.31, 129.54, 130.14,
2
133.02, 133.91, 134.05, 134.46, 134.56 (d, JP,C = 9 Hz), 134.77,
2
2
(d, 2H, ArCH2Ar, JH,H = 15 Hz), 3.62 (d, 2H, ArCH2Ar, JH,H
=
134.84, 136.19, 154.37, 156.24, 156.42, 156.72; 31P{1H} NMR
(CDCl3): ¤ ¹15.8.
15 Hz), 3.75 (d, 2H, ArCH2Ar, 2JH,H = 15 Hz), 4.13 (d, 2H,
2
2
ArCH2Ar, JH,H = 15 Hz), 4.21 (d, 2H, ArCH2Ar, JH,H = 15 Hz),
4.37 (d, 2H, ArCH2Ar, 2JH,H = 15 Hz), 4.90 (s, 2H), 6.80 (br.s,
2H), 6.81 (s, 2H), 6.86 (br.s, 3H), 7.10 (br.s, 2H), 7.13 (s, 2H), 7.18
(br.s, 2H), 7.39 (br.t, 4H, J = 7.8 Hz), 7.48 (br.t, 3H, J = 6.0 Hz),
7.64-7.70 (m, 4H), 7.78 (d, 1H, J = 5.0 Hz), 7.80 (s, 1H);
13C{1H} NMR (CDCl3): ¤ 30.32, 30.43, 30.53, 31.27, 31.36,
31.62, 34.14, 34.25, 59.97, 60.13, 73.86, 124.50, 124.85, 124.98,
126.95, 127.12, 127.42, 128.53, 128.65, 131.98 (d, 2JP,C = 11 Hz),
132.12, 132.23, 133.10 (d, 2JP,C = 11 Hz), 133.28, 133.38, 133.65,
133.78, 145.73, 145.79, 153.52, 154.37; 31P{1H} NMR (CDCl3):
¤ 29.6.
37-(3-Diphenylphosphinoylbenzyloxy)-38,39,40,41,42-penta-
methoxycalix[6]arene (7b). The compound was synthesized with
5b (0.13 g, 0.35 mmol) and 4 (0.21 g, 0.29 mmol) by a method
similar to that used for 6a. Pale-yellow solids were obtained
(0.33 g, 95%). Anal. Calcd for C66H61O7P¢CHCl3¢MeOH: C,
71.11; H, 5.79%. Found: C, 71.03; H, 5.64%. HR-ESI-MS m/z
calcd for [M + Na]+: 1020.1499; found: 1019.4043. 1H NMR
(CDCl3): ¤ 2.89 (s, 6H, OCH3), 3.16 (s, 3H, OCH3), 3.22 (s, 6H,
OCH3), 3.89 (s, 4H, ArCH2Ar), 3.92 (s, 4H, ArCH2Ar), 3.97 (s,
4H, ArCH2Ar), 4.79 (s, 2H), 6.76-7.05 (m, 20H), 7.37 (br.t, 4H
J = 4 Hz), 7.43-7.49 (m, 2H), 7.54 (d, 1H, J = 8 Hz), 7.66-7.79